Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Aug 17;83(6):756–760. doi: 10.1054/bjoc.2000.1364

CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL)

P Vorwerk 1, H Wex 1, B Hohmann 1, Y Oh 2, R G Rosenfeld 2, U Mittler 1
PMCID: PMC2363531  PMID: 10952780

Abstract

Connective tissue growth factor (CTGF) is a major chemotactic and mitogenic factor for connective tissue cells. The amino acid sequence shares an overall 28–38% identity to IGFBPs and contains critical conserved sequences in the amino terminus. It has been demonstrated that human CTGF specifically binds IGFs with low affinity and is considered to be a member of the IGFBP superfamily (IGFBP-rP2). In the present study, the expression of CTGF (IGFBP-rP2) in human leukaemic lymphoblasts from children with acute lymphoblastic leukaemia (ALL) was investigated. RNA samples from tumour clones enriched by ficoll separation of bone marrow or peripheral blood mononuclear cells (MNC) from 107 patients with childhood ALL at diagnosis and 57 adult patients with chronic myeloid leukaemia (CML) were studied by RT-PCR. In addition MNC samples from children with IDDM and cord blood samples from healthy newborns were investigated as control groups. Sixty-one percent of the patients with ALL (65 of 107) were positive for CTGF (IGFBP-rP2) expression. In the control groups, no expression of CTGF (IGFBP-rP2) in peripheral MNC was detected, and in the group of adult CML patients only 3.5% (2 of 57) were positive for this gene. The role of CTGF (IGFBP-rP2) in lymphoblastic leukaemogenesis requires further evaluation, as does its potential utility as a tumour marker. © 2000 Cancer Research Campaign

Keywords: CTGF, IGFBP-rP2, mRNA, acute lymphoblastic leukaemia, cell line

Full Text

The Full Text of this article is available as a PDF (346.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baxter R. C., Binoux M. A., Clemmons D. R., Conover C. A., Drop S. L., Holly J. M., Mohan S., Oh Y., Rosenfeld R. G. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology. 1998 Oct;139(10):4036–4036. doi: 10.1210/endo.139.10.5083. [DOI] [PubMed] [Google Scholar]
  2. Bradham D. M., Igarashi A., Potter R. L., Grotendorst G. R. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol. 1991 Sep;114(6):1285–1294. doi: 10.1083/jcb.114.6.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burren C. P., Wilson E. M., Hwa V., Oh Y., Rosenfeld R. G. Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily. J Clin Endocrinol Metab. 1999 Mar;84(3):1096–1103. doi: 10.1210/jcem.84.3.5577. [DOI] [PubMed] [Google Scholar]
  4. Frazier K. S., Grotendorst G. R. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol. 1997 Jan;29(1):153–161. doi: 10.1016/s1357-2725(96)00127-6. [DOI] [PubMed] [Google Scholar]
  5. Hishikawa K., Oemar B. S., Tanner F. C., Nakaki T., Lüscher T. F., Fujii T. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem. 1999 Dec 24;274(52):37461–37466. doi: 10.1074/jbc.274.52.37461. [DOI] [PubMed] [Google Scholar]
  6. How H. K., Yeoh A., Quah T. C., Oh Y., Rosenfeld R. G., Lee K. O. Insulin-like growth factor binding proteins (IGFBPs) and IGFBP-related protein 1-levels in cerebrospinal fluid of children with acute lymphoblastic leukemia. J Clin Endocrinol Metab. 1999 Apr;84(4):1283–1287. doi: 10.1210/jcem.84.4.5587. [DOI] [PubMed] [Google Scholar]
  7. Hwa V., Oh Y., Rosenfeld R. G. Insulin-like growth factor binding proteins: a proposed superfamily. Acta Paediatr Suppl. 1999 Feb;88(428):37–45. doi: 10.1111/j.1651-2227.1999.tb14349.x. [DOI] [PubMed] [Google Scholar]
  8. Hwa V., Oh Y., Rosenfeld R. G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 1999 Dec;20(6):761–787. doi: 10.1210/edrv.20.6.0382. [DOI] [PubMed] [Google Scholar]
  9. Igarashi A., Hayashi N., Nashiro K., Takehara K. Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors. J Cutan Pathol. 1998 Mar;25(3):143–148. doi: 10.1111/j.1600-0560.1998.tb01706.x. [DOI] [PubMed] [Google Scholar]
  10. Jones J. I., Clemmons D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995 Feb;16(1):3–34. doi: 10.1210/edrv-16-1-3. [DOI] [PubMed] [Google Scholar]
  11. Kim H. S., Nagalla S. R., Oh Y., Wilson E., Roberts C. T., Jr, Rosenfeld R. G. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):12981–12986. doi: 10.1073/pnas.94.24.12981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mohnike K. L., Kluba U., Mittler U., Aumann V., Vorwerk P., Blum W. F. Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia. Eur J Pediatr. 1996 Feb;155(2):81–86. doi: 10.1007/BF02075755. [DOI] [PubMed] [Google Scholar]
  13. Müller H. L., Oh Y., Gargosky S. E., Wilson K. F., Lehrnbecher T., Rosenfeld R. G. Insulin-like growth factor binding protein-3 concentrations and insulin-like growth factor binding protein-3 protease activity in sera of patients with malignant solid tumors or leukemia. Pediatr Res. 1994 Jun;35(6):720–724. doi: 10.1203/00006450-199406000-00019. [DOI] [PubMed] [Google Scholar]
  14. Oh Y., Gucev Z., Ng L., Müller H. L., Rosenfeld R. G. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. Prog Growth Factor Res. 1995;6(2-4):503–512. doi: 10.1016/0955-2235(95)00025-9. [DOI] [PubMed] [Google Scholar]
  15. Oh Y., Müller H. L., Lamson G., Rosenfeld R. G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem. 1993 Jul 15;268(20):14964–14971. [PubMed] [Google Scholar]
  16. Oh Y., Nagalla S. R., Yamanaka Y., Kim H. S., Wilson E., Rosenfeld R. G. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem. 1996 Nov 29;271(48):30322–30325. doi: 10.1074/jbc.271.48.30322. [DOI] [PubMed] [Google Scholar]
  17. Rosenfeld R. G., Pham H., Cohen P., Fielder P., Gargosky S. E., Muller H., Nonoshita L., Oh Y. Insulin-like growth factor binding proteins and their regulation. Acta Paediatr Suppl. 1994 Apr;399:154–158. doi: 10.1111/j.1651-2227.1994.tb13315.x. [DOI] [PubMed] [Google Scholar]
  18. Rothe G., Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Leukemia. 1996 May;10(5):877–895. [PubMed] [Google Scholar]
  19. Westley B. R., May F. E. Insulin-like growth factors: the unrecognised oncogenes. Br J Cancer. 1995 Nov;72(5):1065–1066. doi: 10.1038/bjc.1995.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wex H., Vorwerk P., Mohnike K., Bretschneider D., Kluba U., Aumann V., Blum W. F., Mittler U. Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone. Br J Cancer. 1998 Aug;78(4):515–520. doi: 10.1038/bjc.1998.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Yang D. H., Kim H. S., Wilson E. M., Rosenfeld R. G., Oh Y. Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J Clin Endocrinol Metab. 1998 Jul;83(7):2593–2596. doi: 10.1210/jcem.83.7.5097. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES